The role of sexually transmitted diseases in HIV transmission

Nature Reviews Microbiology

Volumn 2, Issue 1, 2004, Pages 33-42

  Galvin, Shannon R ^a   Cohen, Myron S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; RETINOL; VIRUS RNA; ZIDOVUDINE;

AFRICA; CHINA; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; EPIDEMIC; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MALE; POPULATION DISTRIBUTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RUSSIAN FEDERATION; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URETHRITIS; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING; HIGH RISK BEHAVIOR; HUMAN IMMUNODEFICIENCY VIRUS 1; PATHOGENICITY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

DISEASE SUSCEPTIBILITY; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; RISK-TAKING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES;

EID: 1842486661     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro794     Document Type: Review

References (112)

1. May, R. M. & Anderson, R. M. Transmission dynamics of HIV infection. Nature 326, 137-142 (1987).
2. Shattock, R. J. & Moore, J. P. Inhibiting sexual transmission of HIV-1 infection. Nature Rev. Microbiol. 1, 25-34 (2003).
3. Will, G. F. AIDS crushes a continent. Newsweek 135 64 (2000).
4. Gisselquist, D., Rothenberg, R., Potterat, J. & Drucker, E. HIV infections in sub-Saharan Africa not explained by sexual or vertical transmission. Int. J. STD AIDS 13, 657-666 (2002).
5. Royce, R. A., Sena, A., Cates, W. & Cohen, M. S. Sexual transmission of HIV. N. Engl. J. Med. 336, 1072-1078 (1997 ).
6. Cohen, M. S. Preventing sexual transmission of HIV - new ideas from sub-Saharan Africa N. Engl. J. Med. 342, 970-972 (2000).
7. Gray, R. H. et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1 discordant couples in Rakai, Uganda. Lancet 357, 1149-1153 (2001).
8. Auvert, B. et al. Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Suharan Africa with different levels of HIV infection. AIDS 15, S15-S30 (2001).
9. Leroy, V. et al. Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial. AIDS 15, 517-522 (2001).
10. Thea, D. M. et al. The effect of maternal viral load or the risk of perinatal transmission of HIV-1. AIDS 11, 437-444 (1997).
11. Connor, E. M. et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331, 1173-1180 (1994).
12. Quinn, T. C. et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N. Engl J. Med. 342, 921-929 (2000).
13. Lafeuillade, A. et al. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection. J. Acquir. Immune Defic. Syndr. 7, 1028-1033 (1994).
14. + cell counts in HIV-infected patients. Arch. Int. Med. 158, 247-252 (1998).
15. Sulkowski, M. S. et al. The effect of acute infectious illness on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J. Infect Dis. 178, 1642-1648 (1998).
16. Toossi, Z. et al. Impact of tuberculosis on HIV-1 activity in dually infected patients. Clin. Exp. Immunol. 123 233-238 (2001).
17. Hoffman, I. F. et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentrations. AIDS 13, 487-494 (1999).
18. Mole, L., Ripich, S., Margolis, D. & Holodniy, M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J. Infect. Dis. 176, 766-770 (1997).
19. Wolday, D. et al. Treatment of intestinal worms is associated with decreased HIV plasma viral load. J. Acquir. Immune Defic. Syndr. 31, 56-62 (2002).
20. Koopman, J. S. et al. The role of early HIV infection in the spread of HIV through populations. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14, 249-258 (1997).
21. Musey, L. et al. Cytotoxic, T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337, 1267-1274 (1997).
22. + index partner, in discordant couples, Rakai, Uganda. Abstract 40. Tenth conference on retroviruses and opportunistic infections, Boston, USA (2003).
23. Pilcher, C. D. et al. Frequent detection of acute primary HIV infection in men in Malawi: reconsideration of counseling and testing approaches. Abstract 154. Tenth conference on retroviruses and opportunistic infections, Boston, USA (2003).
24. Pilcher, C. D. et al. Semen viral dynamics in acute HIV infection: implications for sexual transmission. XIV International AIDS Conference, Barcelona. [online], (cited 7 Nov 2003), (2002).
25. Dyer, J. R. et al. High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J. Infect. Dis. 177, 1742-1746 (1998).
26. Chakraborty, H. et al. Viral burden genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 15, 621-627 (2001).
27. Hart, C. E. et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J. Infect. Dis. 179, 871-882 (1999).
28. Chakraborty, H., Helms, R. W., Sen, P. K. & Cohen, M. S. Estimating correlation by using a general linear mixed model: avaluation of the relationship between the concentration of HIV-1 RNA in blood and semen. Stat. Med. 22, 1457-1464 (2003).
29. Gupta, P. et al. High viral load in semen of human immunodeficiency virus type-1 infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J. Virol. 71, 6271-6275 (1997).
30. Cu-Uvin, S. et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS 14, 415-421 (2000).
31. Vernazza, P. et al. Potent antiretroviral treatment of HIV-1 infection results in suppression of the seminal shedding of HIV. AIDS 14, 117-121 (2000).
32. John, G. C. et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J. Infect. Dis. 175, 57-62 (1997).
33. Ghys, P. D. et al. The association between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 11, F85-F93 (1997).
34. Fleming, D. T. & Wasserheit, J. N. From epidemiological synergy to public health policy and practice: the contribution of other diseases to sexually transmitted diseases to sexual transmission of HIV infection. Sex. Trans. Infect. 75, 3-17 (1999).
35. Rottingen, J.-A., Cameron, D. W. & Garnett, G. P. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV. Sex. Trans. Dis. 28, 579-597 (2001).
36. Coombs, R. W., Reichelderfer, P. S. & Landay, A. L. Recent observations on HIV type 1 infection in the genital tract of men and women. AIDS 17, 455-480 (2003).
37. Mostad, S. B. et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 350, 922-927 (1997).
38. Baeten, J. M. et al. Selenium deficiency is associated with shedding of HIV-1 infected cells in the female genital tract. J. Acquir. Immune Defic. Syndr. 26, 360-364 (2001).
39. Baeten, J. M. et al. Vitamin A supplementation and human immunodeficiency virus type 1 shedding in women: results of a randomized clinical trial. J. Infect. Dis. 185, 1187-1191 (2002).
40. Shey, W. I., Brocklehurst & Sterne, J. A. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst. Rev. 3, CD003648; 2002.
41. Fawzi W. W. et al. Randomized trial of vitamin A supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS 16, 1935-1944 (2002).
42. Hogan, C. M. & Hammer, S. M. Host determinants in HIV infection and disease part 2: genetic factors and implications for antiretroviral therapeutics. Ann. Intern. Med. 134, 978-996 (2001).
43. Ping, L. H. et al. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: under-representation of X4 variants. J. Virol. 73 6271-6281 (1999).
44. Halperin, D. T. Dry sex practices and HIV infection in the Dominican Republic and Haiti. Sex. Trans. Infect. 75, 445-446 (1999).
45. Van Damme, L. et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomized controlled trial. Lancet 360, 971-977 (2002).
46. Al Jabri, A. A. HLA and in vitro susceptibility to HIV infection. Mol. Immunol. 38, 959-967 (2002).
47. Sibbald, B. India and China face AIDS crisis. CMAJ 169, 330 (2003).
48. Lehner, T. The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection. Trends Immunol. 23, 347-351 (2002).
49. Feng, T. et al. Distribution of the CCR5 gene 32-base-pair deletion and CCR5 expression in Chinese minorities. J. Acquir. Immune Defic. Syndr. 32, 131-134 (2003).
50. Overbaugh, J. et al. Studies of human immunodeficiency virus type 1 mucosal viral shedding and transmission in Kenya. J. Infect. Dis. 179, S401-S404 (1999).
51. Long, E. M. et al. Gender differences in HIV-1 diversity at time of infection. Nature Med. 6, 71-75 (2000 ).
52. Smith, S. M., Baskin, G. B. & Marx, P. A. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J. Infect. Dis. 182, 708-715 (2000).
53. Mbopi-Keou, F. X. et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J. Infect. Dis. 182, 1090-1096 (2000).
54. Plummer, F. A. et al. Detection of human immunodeficiency virus type 1 (HIV-1) in genital ulcer exudate of HIV-infected men by culture and gene amplification. J. Infect. Dis. 161, 810-811 (1990).
55. Wright, T. C. Jr, et al. Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am. J. Obst. Gyn. 184, 279-285 (2001).
56. Dyer, J. R. et al. Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 RNA concentrations with genital ulcer disease in HIV-1 infected men in Malawi. J. Infect. Dis. 177, 224-227 (1998).
57. Celum, C. L., Robinson, N. J. & Cohen, M. S. Potential impact of antiviral therapy for HSV-2 and HIV on transmission and acquisition of HIV infection. J. Infect. Dis. (in the press).
58. Chen, C. Y. et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex. Trans. Dis. 27, 21-29 (2000).
59. Shacker, T. et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1 infected men. JAMA 280, 61-66 (1998).
60. Schacker, T., Zeh, J., Hu, H., Shaughnessy, M. & Corey, L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J. Infect. Dis. 186, 1718-1725 (2002).
61. McClelland, R. S. et al. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS 16, 2425-2430 (2002).
62. Hobbs, M. M. et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex. Trans. Dis. 26, 381-387 (1999).
63. Price, M. A. et al. Addition of treatment for trichomonas to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex. Trans. Dis. 30, 516-522 (2003).
64. Winter, A. J. et al. A symptomatic urethritis and detection of HIV-1 RNA in seminal plasma. Sex. Trans. Infect. 75 261-263 (1999).
65. Speck, C. E. et al. Risk factors for HIV-1 shedding in semen. Am. J. Epidemiol. 150, 622-631 (1999).
66. Cohen, M. S. et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 349, 1868-1873 (1997).
67. Rotchford, K., Strum, A. W. & Wilkinson, D. Effect of coinfection with STDs and of STD treatment on HIV shedding in genital tract secretions: systematic review and data synthesis. Sex. Trans. Dis. 27, 243-248 (2000).
68. McClelland, R. S. et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 15 105-110 (2001).
69. Anzala, A. O. et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 counts. J. Infect. Dis. 182, 459-466 (2000).
70. Ho, J. L. et al. Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. J. Exp. Med. 190, 1493-1505 (1995).
71. Mercader, M., Nickoloff, B. J. & Foreman, K. E. Induction of human immunodeficiency virus type 1 replication by human herpesvirus 8. Arch. Pathol. Lab. Med. 125, 785-789 (2001).
72. Theus, S. A., Harrich, D. A., Gaynor, R., Radolf J. D. & Norgard, M. V. Treponema pallidum, lipoproteins, and synthetic lipoprotien analogues induce human immunodeficiency virus type-1 gene expression in monocytes via NF-κB activation. J. Infect. Dis. 177, 941-950 (1998).
73. Mostad, S. B. et al. Cervical shedding of cytomegalovirus in human immunodeficiency virus type 1 infected women. J. Med. Virol. 59, 469-473 (1999).
74. Holmes, K. K. et al. (eds) Sexually Transmitted Disease (McGraw Hill, New York. 1999).
75. Corey, L. et al. Once daily valacyclovir reduces trasmission of genital herpes. Forty-second interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, USA. [online], (cited 7 Nov 2003), (2002).
76. Reynolds, S. J. et al. Recent herpes simplex virus type 2 acquisition and the risk of human immunodeficiency virus type 1 acquisition in India. J. Infect. Dis. 187, 1513-1521 (2003 ).
77. Ping, L. H. et al. Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J. Virol. 74, 8946-8952 (2000).
78. Zhang, H. et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. New Engl. J. Med. 339, 1803-1808 (1998).
79. Eron, J. J. et al. Resistance of HIV-1 to antiretroviral agents in the blood and seminal plasma: implications for transmission. AIDS 12, F181-189 (1998).
80. Pereira, A. S. et al. The pharmokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1. J. Infect. Dis. 186, 198-204 (2002).
81. Sadiq, S. T. et al. The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. AIDS 16, 219-225 (2002).
82. Cameron, D. W. et al. Female-to-male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 2, 403-407 (1989).
83. Nelson, K. E. et al. The association of herpes simplex type 2, Haemophilus ducreyi, and syphilis with HIV infection in young men in northern Thailand. J. Acquir. Immune Defic. Syndr. Hum. Retrovir. 16, 293-300 (1997).
84. Plummer, F. A. et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J. Infect. Dis. 163, 233-239 (1991).
85. Kassler, W. J. et al. Seroconversion in patients attending sexually transmitted disease clinics. AIDS 8, 351-355 (1994).
86. Laga, M. et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7, 95-102 (1993).
87. Dickerson, M. C., Johnston, J., Delea, T. E., White, A. & Andrews, E. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. Sex. Trans. Dis. 23, 429-440 (1996).
88. Mehendale, S. M. et al. Incidence and predictors of human immunodeficiency virus type 1 seroconversion in patients attending sexually transmitted disease clinics in India. J. Infect. Dis. 172, 1486-1491 (1995).
89. Collins, K. B., Patterson, B. K., Naus, G. J., Landers, D. V. & Gupta, P. Development of an in vitro organ tissue culture model to study transmission of HIV-1 in the female genital tract. Nature Med. 6, 475-479 (2000).
90. + T cells are the earliest detectable human immunodeficiency virus type-1 (HIV-1) infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J. Virol. 76 9868-9876 (2002).
91. Miller, C. J. & Shattock, R. J. Target cells in vaginal HIV transmission. Microbes Infect. 5, 59-67 (2003).
92. Hladik, F., Lentz, G., Delpit, E., McElroy, A. & McElrath, M. J. Coexpression of CCR5 and 62 IL-2 in human genital but not blood cells: implications for the ontogeny of the CCR5 Th1 phenotype. J. Immunol. 163, 2306-2313 (1999).
93. Patterson, B. K. et al. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am. J. Pathol. 153, 481-490 (1998).
94. Sellati, T. J. et al. Virulent Treponema pallidum lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance susceptibility to infection by human immunodeficiency virus type 1. J. Infect. Dis. 181, 283-293 (2000).
95. + chancroid patients by Haemophilus ducreyi antigens. Clin. Exp. Immunol. 102, 243-250 (1995).
96. Magro, C. M. et al. A morphological study of penile chancroid lesions in human immunodeficiency virus positive and negative African men with a hypothesis concerning the role of chancroid in HIV transmission. Hum. Pathol. 27, 1066-1070 (1996).
97. Levine, W. C. et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J. Infect. Dis. 177, 167-174 (1998).
98. Taha, T. E. et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12, 1699-1706 (1998).
99. Martin, H. L. et al. Vaginal lactobacilli, microbial flora and the risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180, 1863-1868 (1999).
100. Klebanoff, S. J. & Coombs, R. W. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J. Exp. Med. 174, 289-292 (1991).
101. Wawer, M. J. et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomized community trial. Lancet 353, 525-535 (1999).
102. Patterson, B. K. et al. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am. J. Pathol. 161, 867-873 (2002).
103. Gray, R. H. et al. Made circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. AIDS 14, 2371-2381 (2000).
104. Bailey, R. C., Plummer, F. A. & Moses, S. Male circumcision and HIV prevention: current knowledge and future research directions. Lancet Infect. Dis. 1, 223-231 (2001).
105. Buve, A. et al. The multicentre study on factors determining the differential spread of HIV in four African cities: summary and conclusions. AIDS 15, S127-S131 (2001).
106. Grosskurth, H. et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet 346, 530-536 (1995).
107. Kamali, A. et al. Syndromic management of sexually-transmitted infections and behavior change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet 361, 645-652 (2003).
108. Moses, S. et al. Monthly azithromycin chemoprophylaxis in Kenyan female sex workers reduces the incidence of STIs but not HIV: a randomized, placebo-controlled trial. Abstract 27. Fifteenth International Society for Sexually Transmitted Diseases Research Congress, Ottawa, Canada (2003).
109. Korenromp, E. L. et al. HIV dynamics and behavior change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trial. AIDS 16, 2209-2218 (2002).
110. Kelly, J. A. & Amirkhanian, Y. A. The newest epidemic: a review of HIV/AIDS in central and eastern Europe. Int J. STD AIDS 14, 361-371 (2003).
111. Cohen M. S., Ping, G., Fox, K. & Henderson, G. E. Sexually transmitted diseases in the People's Republic of China Y2K: back to the future. Sex. Trans. Dis. 27, 143-145 (2000).
112. Rogers S. J. et al. Reaching and identifying the STD/HIV risk of sex workers in Beijing. AIDS Educ. Prev. 14, 217-227 (2002).